Christine Mikail Cvijic, President and CFO at Neurogene Inc. (NGNE), sold 4,800 shares at $36.02 ($173K) on 2026-07-06, disclosed to the SEC on 2026-07-07.
Scheduled sale ($173k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.02 | 600 | $22K | 12.5% |
| 2 | $36.13 | 4,200 | $152K | 87.5% |
| Total | $36.12 avg | 4,800 | $173K | 100% |
| Filing → |
| NGNE | SELL | 2026-03-30 | $111K | — | Filing → |
| NGNE | SELL | 2026-03-17 | $168K | — | Filing → |
| NGNE | SELL | 2026-03-03 | $121K | — | Filing → |